The Trump administration plans to ensure transparency and accuracy in drug ads, including by increasing the amount of ...

HHS and FDA argue that direct-to-consumer pharmaceutical ads have "distorted physician prescribing habits and patient ...

HHS and the FDA are taking measures to crack down on misleading pharmaceutical advertisements, including digital and broadcast drug ads. The FDA is sending roughly 100 cease-and-desist letters and ...

The administration is planning to take regulatory action to require companies to include more drug information ...

President Trump signed a memo on Tuesday directing the FDA to crack down on direct-to-consumer drug advertisements. But there are limits to what any administration can do.

The Trump administration announced plans to crack down on pharmaceutical advertising on television and social media platforms that could disrupt billions of dollars in annual ad spending.

The Trump administration is planning to ramp up oversight and enforcement of direct-to-consumer prescription drug advertising ...

President Donald Trump is aiming to ramp up scrutiny on pharmaceutical ads — both on TV and social media — as his ...

President Donald Trump signed a memorandum Tuesday directing the Food and Drug Administration (FDA) to crack down on ...

A coalition of criminal justice advocacy organizations has launched "It's Not Fair. It's Not Working," an ad campaign and national effort to reform the federal sentencing disparity ratio between crack ...